CMS certification 050077
Scripps Mercy Hospital
4077 5th Ave, San Diego, CA 92103
Scripps Mercy Hospital has a CMS overall rating of 4 out of 5 stars. 69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. Emergency patients spend a median of 3 h 14 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 3,127 completed surveys, 19% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | CA | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 345 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 14 min | 2 h 54 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 42 visits sampled | 3 h 28 min | 4 h 20 min | 4 h 17 min |
| Left before being seen Lower is better · 138,220 patients | 3% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 15 patients | 87% | 74% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 232 patients | 86% | 70% | 65% |
How Scripps Mercy Hospital compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Scripps Mercy HospitalThis hospital | 4/5 | 69% | 3 h 14 min | 4 better 3 worse |
| Uc San Diego Health Hillcrest - Hillcrest Med CtrSame city | 5/5 | 75% | 4 h 19 min | 10 better 2 worse |
| Kaiser Foundation Hospital - San DiegoSame city | 4/5 | 77% | — | 3 better |
| Sharp Memorial HospitalSame city | 4/5 | 81% | 3 h 17 min | 4 better 2 worse |
| NMC San DiegoSame city | Not rated | 77% | 2 h 46 min | — |
| VA San Diego Healthcare SystemSame city | 5/5 | 74% | — | 3 better 2 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in San Diego.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,575 cases | Too few cases | 2.6% | 3.9% |
| Heart attack 100 cases | Too few cases | 11.1% | 11.9% |
| Heart failure 400 cases | Too few cases | 10.5% | 11.1% |
| Pneumonia 388 cases | Too few cases | 15.5% | 15.2% |
| Stroke 503 cases | Too few cases | 10% | 11.9% |
| COPD 115 cases | Too few cases | 6.9% | 8.6% |
1 more measure had too few cases here to report.
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.92 likely 0.64 – 1.21 | 1 |
| After hip or knee replacement 389 cases | Too few cases | 3.4% | 4.1% |
| Deaths after a serious but treatable surgical complication 118 cases | No different | 140.2 per 1,000 likely 94.53 per 1,000 – 185.86 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 6,094 cases | No different | 0.11 per 1,000 likely 0 per 1,000 – 0.66 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 8,056 cases | No different | 0.31 per 1,000 likely 0.12 per 1,000 – 0.5 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 8,169 cases | No different | 0.3 per 1,000 likely 0.12 per 1,000 – 0.49 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 1,824 cases | No different | 3.52 per 1,000 likely 2.12 per 1,000 – 4.93 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 666 cases | No different | 1.26 per 1,000 likely 0 per 1,000 – 2.77 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 707 cases | No different | 7.77 per 1,000 likely 1.62 per 1,000 – 13.93 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 1,962 cases | No different | 3.77 per 1,000 likely 1.85 per 1,000 – 5.69 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 678 cases | No different | 7.17 per 1,000 likely 3.71 per 1,000 – 10.62 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 345 cases | No different | 1.9 per 1,000 likely 0.45 per 1,000 – 3.36 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 1,395 cases | No different | 1.62 per 1,000 likely 0.69 per 1,000 – 2.56 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | No different | 0.65 likely 0.3 – 1.23 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.43 likely 0.19 – 0.85 | 1 |
| Surgical site infections after colon surgery | No different | 1.03 likely 0.38 – 2.29 | 1 |
| MRSA bloodstream infections | No different | 1.09 likely 0.57 – 1.89 | 1 |
| C. diff intestinal infections | Better | 0.17 likely 0.1 – 0.26 | 1 |
1 more measure had too few cases here to report.
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 291 cases | Too few cases | 14.9% | 14.4% |
| Readmitted after heart failure 1,123 cases | Too few cases | 21.9% | 21.3% |
| Readmitted after pneumonia 851 cases | Too few cases | 17.6% | 17.3% |
| Readmitted after COPD 350 cases | Too few cases | 19.2% | 20% |
| Readmitted after heart bypass surgery 55 cases | Too few cases | 11% | 11% |
| Readmitted after hip or knee replacement 392 cases | Too few cases | 5.1% | 5.8% |
| Days back in hospital after a heart attack 104 cases | Too few cases | -2.7 days per 100 | — |
| Days back in hospital after heart failure 472 cases | Too few cases | 9.2 days per 100 | — |
| Days back in hospital after pneumonia 411 cases | Too few cases | 19.3 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 480 cases | No different | 15 per 1,000 likely 11.3 per 1,000 – 19.9 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 229 cases | No different | 12.6 per 100 likely 9.6 per 100 – 16 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 229 cases | No different | 7.2 per 100 likely 5.1 per 100 – 10 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 264 cases | No different | 1 likely 0.7 – 1.3 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
55 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Emergency Medicine | 7 |
| Pharmacist | 7 |
| Family | 6 |
| Clinical | 5 |
| Internal Medicine | 3 |
| Endocrinology, Diabetes & Metabolism | 2 |
| Hospitalist | 2 |
| Marriage & Family Therapist | 2 |
| Psychiatric/Mental Health | 2 |
| Acute Care | 1 |
| Adult Health | 1 |
| Anesthesiology | 1 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $3M
- 2020 $1.8M
- 2021 $2.3M
- 2022 $2.9M
- 2023 $2.7M
- 2024 $3.1M
- 2025 $4.1M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Grants | $414,115 | 47 |
| Space rental and facility fees | $401,900 | 82 |
| Speaking, teaching and other services | $225,371 | 36 |
| Consulting fees | $64,150 | 3 |
| Education | $36,394 | 7 |
| Debt forgiveness | $10,597 | 12 |
| Charitable contributions | $10,000 | 1 |
| Medical devices and supplies on long-term loan | $5,776 | 7 |
| Food and beverage | $120 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Eli Lilly and Company | $500,541 | 9 |
| Merck Sharp & Dohme LLC | $473,546 | 12 |
| Abbvie INC. | $448,469 | 45 |
| Edwards Lifesciences Corporation | $400,876 | 48 |
| Boston Scientific Corporation | $382,527 | 77 |
| Abbott Laboratories | $220,900 | 34 |
| Regeneron Pharmaceuticals, Inc. | $216,457 | 36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168,970 | 16 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFECT OF LEPODISIRAN ON THE REDUCTION OF MAJOR ADVERSE CARDIOVASCUL… Eli Lilly and Company · NCT06292013 | $226,465 |
| A Phase 3, Randomized, Open-label, Study to Compare the Efficacy and Safety of Adjuvant MK-2870 in Combination with Pembrolizumab MK-3475 Versus Trea… Merck Sharp & Dohme LLC | $222,846 |
| A Phase 2, Double-blind, Randomized, Placebo-controlled Study to Evaluate the Effects of Sotatercept versus Placebo for the Treatment of Combined Pos… Merck Sharp & Dohme LLC | $185,905 |
| A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB (LOXO-305) PLUS VENETOCLAX AND RITUXIMAB VERSUS VENETOCLAX AND RITUXIMAB IN PR… Eli Lilly and Company · NCT04965493 | $181,323 |
| MECHANISMS OF DUPILUMAB IN AERD - EFFECTS ON ASPIRIN HYPERSENSITIVITY RESPONSE, WITH A FOCUS ON INNATE TYPE 2 INFLAMMATORY RESPONSES Regeneron Pharmaceuticals, Inc. | $174,702 |
| Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease… ABBVIE INC. · NCT06191744 | $144,419 |
| Prospective, Multicenter, Single-Arm IDE Study of the Shockwave Coronary Intravascular Lithotripsy (IVL) System With the Shockwave C2+ 2Hz Coronary I… Shockwave Medical, Inc | $103,209 |
| A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Partic… ABBVIE INC. · NCT06345339 | $96,624 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Scripps Mercy Hospital
Is Scripps Mercy Hospital a good hospital?
Scripps Mercy Hospital has a CMS overall rating of 4 out of 5 stars. Of the 26 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 4 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Scripps Mercy Hospital?
69% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 3,127 completed HCAHPS surveys.
How long is the wait in the Scripps Mercy Hospital emergency room?
Emergency patients spend a median of 3 h 14 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 3% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Scripps Mercy Hospital receive money from drug and device companies?
Drug and device makers reported $4.1M in payments to Scripps Mercy Hospital for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.